BIAWX
Price
$47.18
Change
-$0.24 (-0.51%)
Updated
Jul 13 closing price
Net Assets
4.35B
GFACX
Price
$71.84
Change
-$1.16 (-1.59%)
Updated
Jul 13 closing price
Net Assets
356.86B
Interact to see
Advertisement

BIAWX vs GFACX

BIAWX vs GFACX Comparison Chart in %
View a ticker or compare two or three
VS
BIAWX vs. GFACX commentary
Jul 14, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BIAWX is a StrongBuy and GFACX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
GFACX has more cash in the bank: 357B vs. BIAWX (4.35B). BIAWX (0.00) and GFACX (0.00) have matching dividends . BIAWX was incepted earlier than GFACX: BIAWX (14 years) vs GFACX (25 years). GFACX (1.35) is less costly to investors than BIAWX (0.75). BIAWX (32.00) and GFACX (32.00) have comparable annual turnover. BIAWX has a lower initial minimum investment than GFACX: BIAWX (100) vs GFACX (250). GFACX annual gain was more profitable for investors over the last year : 1.73 vs. BIAWX (-16.43). GFACX return over 5 years is better than : 6.34 vs. BIAWX (5.42).
BIAWXGFACXBIAWX / GFACX
Total Expense Ratio0.751.3556%
Annual Report Gross Expense Ratio0.751.3556%
Fund Existence14 years25 years-
Gain YTD5.9906.74689%
Front LoadN/AN/A-
Min. Initial Investment10025040%
Min. Initial Investment IRAN/AN/A-
Net Assets4.35B357B1%
Annual Yield % from dividends0.000.00-
Returns for 1 year-16.431.73-951%
Returns for 3 years8.8631.0928%
Returns for 5 years5.426.3486%
Returns for 10 years187.2278.97237%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ONCY0.930.04
+4.69%
Oncolytics Biotech
RS385.406.18
+1.63%
Reliance
VINP9.79-0.22
-2.15%
Vinci Compass Investments Ltd
TTAM16.96-0.39
-2.25%
Titan America SA
ENVB1.31-0.05
-3.68%
Enveric Biosciences Inc.